Drug
TA-650
TA-650 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
100%(6 trials)
Phase Distribution
Ph phase_3
6
100%
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Phase Distribution6 total trials
Phase 3Large-scale testing
6(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 36 (100.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
NCT01680159
completedphase_3
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
NCT00805766
completedphase_3
Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
NCT01585155
completedphase_3
Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
NCT01532570
completedphase_3
Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
NCT01596335
Clinical Trials (6)
Showing 6 of 6 trials
NCT01680159Phase 3
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
NCT00805766Phase 3
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
NCT01585155Phase 3
Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
NCT01532570Phase 3
Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
NCT01596335Phase 3
Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
NCT01580670Phase 3
Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6